Gene therapy developers have been ringing out 2020 with a series of announcements about new manufacturing facilities, or at least production agreements with CDMOs. Thermo Fisher will build at its campus in Carlsbad, CA, while Taysha Gene Therapies disclosed plans in Durham, NC. Also, Passage Bio has announced two manufacturing developments at Catalent Cell & Gene Therapy’s Harmans/BWI campus in Harmans, MD and at the Princeton West Innovation Campus in Hopewell, NJ . . .

Building the Pipeline: Passage Bio Launches Manufacturing Operations
Passage Bio President and CEO Bruce Goldsmith, PhD, details the company’s approach to manufacturing and its progress in developing its pipeline of gene therapies
Passage Bio plans to support lab operations for its gene therapy programs at a new lab at the Princeton West Innovation Campus. The lab will be the company’s second manufacturing facility, following the opening of a facility in Harmans, MD, at the campus of Catalent Cell & Gene Therapy.